Auxogyn Inc.

Menlo Park, CA, United States

Auxogyn Inc.

Menlo Park, CA, United States
SEARCH FILTERS
Time filter
Source Type

News Article | April 18, 2017
Site: marketersmedia.com

— Infertility is the failure to achieve pregnancy after 12 months of unprotected intercourse. Infertility occurs due to the abnormal functioning of the female and male reproductive system. It can be treated with infertility drugs and through procedures such as artificial insemination, in-vitro fertilization, and surrogacy. Read more details of the report at Orbis Research The report covers the present scenario and the growth prospects of the infertility services market in US for 2017-2021. To calculate the market size, the report considers the services carried out during treatment via infertility drugs and assisted reproductive technology (ART) services. Research report, Infertility Services Market in US 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Request sample copy of the report at: http://www.orbisresearch.com/contacts/request-sample/244699 Other prominent vendors • AbbVie • Apricus Biosciences • AstraZeneca • Auxogyn • Eli Lilly • EMD Serono • IKS International • InVitro Care • INVO Bioscience • Irvine Scientific • LifeGlobal • MedITEX • NMC Health • OB GYN Associates • OvaScience • Pantec Biosolutions • Reproductive Medicine Associates of New Jersey • The Sims Clinic • TriHealth • Virtus Health • Xytex Cryo International Market driver • Rising success rate of infertility treatments. • For a full, detailed list, view our report Market challenge • Limited reimbursements and lack of strict regulatory oversight. • For a full, detailed list, view our report Market trend • Upsurge in mergers and acquisitions. • For a full, detailed list, view our report Key questions answered in this report • What will the market size be in 2021 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors? You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report. CARE facility, CooperSurgical, Ferring Pharmaceuticals, Monash IVF, Merck, Vitrolife, AbbVie, Apricus Biosciences, AstraZeneca, Auxogyn, Eli Lilly, EMD Serono, IKS International, InVitro Care, INVO Bioscience, Irvine Scientific, LifeGlobal, MedITEX, NMC Health, OB GYN Associates, OvaScience, Pantec Biosolutions, Reproductive Medicine Associates of New Jersey, The Sims Clinic, TriHealth, Virtus Health, Xytex Cryo International. Enquire more details of the report at: http://www.orbisresearch.com/contact/purchase/244699 About Us: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients. For more information, please visit http://www.orbisresearch.com/reports/index/infertility-services-market-in-us-2017-2021


Apparatuses, methods, and systems for automated cell classification, embryo ranking, and/or embryo categorization are provided. An apparatus includes a classification module configured to apply classifiers to images of one or more cells to determine, for each image, a classification probability associated with each classifier. Each classifier is associated with a distinct first number of cells, and is configured to determine the classification probability for each image based on cell features including one or more machine learned cell features. The classification probability indicates an estimated likelihood that the distinct first number of cells is shown in each image. The classification module is further configured to classify each image as showing a second number of cells based on the distinct first number of cells and the classification probabilities associated therewith. The classification module is implemented in at least one of a memory or a processing device.


Apparatuses, methods, and systems for automated, non-invasive evaluation of cell activity are provided. In one embodiment, an apparatus includes a hypothesis selection module configured to select a hypothesis from a plurality of hypotheses characterizing one or more cells shown in an image. Each of the plurality of hypotheses includes an inferred characteristic of the one or more cells based on geometric features of the one or more cells shown in the image. The hypothesis selection module is implemented in at least one of a memory or a processing device.


Patent
Auxogyn Inc. | Date: 2015-03-11

Methods, compositions and kits for determining the likelihood of reaching the blastocyst stage for one or more embryos or pluripotent cells are provided. These methods, compositions and kits find use in identifying embryos and oocytes in vitro that are most useful in treating infertility in humans.


Methods, compositions and kits for determining the developmental potential of one or more embryos are provided. These methods, compositions and kits find use in identifying embryos in vitro that are most useful in treating infertility in humans.


Methods, compositions and kits for determining the developmental potential of one or more embryos are provided. These methods, compositions and kits find use in identifying embryos in vitro that are most useful in treating infertility in humans.


Methods, compositions and kits for determining the developmental potential of one or more embryos are provided. These methods, compositions and kits find use in identifying embryos in vitro that are most useful in treating infertility in humans.


Patent
Auxogyn Inc. | Date: 2013-05-31

Methods, compositions and kits for determining the likelihood of reaching the blastocyst stage for one or more embryos or pluripotent cells are provided. These methods, compositions and kits find use in identifying embryos and oocytes in vitro that are most useful in treating infertility in humans.


Apparatuses, methods, and systems for the automated imaging and evaluation of human embryos, oocytes, or pluripotent cells are described. An apparatus and method for automated dish detection and well occupancy determination are described. In addition, a multi-well culture dish and an illumination assembly for bimodal imaging are described. These inventions find use at least in identifying or in facilitating identification of embryos and oocytes in vitro that are most useful in treating infertility in humans.


Patent
Auxogyn Inc. | Date: 2013-05-31

Methods, compositions and kits for determining the likelihood of reaching the blastocyst stage for one or more embryos or pluripotent cells are provided. These methods, compositions and kits find use in identifying embryos and oocytes in vitro that are most useful in treating infertility in humans.

Loading Auxogyn Inc. collaborators
Loading Auxogyn Inc. collaborators